Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 280 entries
Sorted by: Best Match Show Resources per page
Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.

Experimental hematology & oncology

Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A, Gabrielli A, Pomponio G.
PMID: 25671135
Exp Hematol Oncol. 2015 Jan 14;4(1):3. doi: 10.1186/2162-3619-4-3. eCollection 2015.

BACKGROUND: Castleman-Kojima disease (TAFRO Syndrome) is characterized by Thrombocytopenia, Anasarca, myeloFibrosis, Renal dysfunction, Organomegaly, multiple lymphadenopathy and histopathology pattern of atypical Castleman's disease (CD). Only few cases of this recently identified unique variant of Multicentric CD (MCD) are described...

Cite
Tedesco S, Postacchini L, Manfredi L, et al. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol. 2015;4(1):3doi: 10.1186/2162-3619-4-3.
Tedesco, S., Postacchini, L., Manfredi, L., Goteri, G., Luchetti, M. M., Festa, A., Gabrielli, A., & Pomponio, G. (2015). Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Experimental hematology & oncology, 4(1), 3. https://doi.org/10.1186/2162-3619-4-3
Tedesco, Silvia, et al. "Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report." Experimental hematology & oncology vol. 4,1 (2015): 3. doi: https://doi.org/10.1186/2162-3619-4-3
Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A, Gabrielli A, Pomponio G. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol. 2015 Jan 14;4(1):3. doi: 10.1186/2162-3619-4-3. eCollection 2015. PMID: 25671135; PMCID: PMC4322808.
Copy Download .nbib Format: NLM
Editorial Introduction.

Journal of genetic counseling

Resta RG.
PMID: 26140906
J Genet Couns. 1997 Dec;6(4):373-4. doi: 10.1023/A:1025640625004.

No abstract available.

Cite
Resta RG. Editorial Introduction. J Genet Couns. 1997;6(4):373-4doi: 10.1023/A:1025640625004.
Resta, R. G. (1997). Editorial Introduction. Journal of genetic counseling, 6(4), 373-4. https://doi.org/10.1023/A:1025640625004
Resta, R G. "Editorial Introduction." Journal of genetic counseling vol. 6,4 (1997): 373-4. doi: https://doi.org/10.1023/A:1025640625004
Resta RG. Editorial Introduction. J Genet Couns. 1997 Dec;6(4):373-4. doi: 10.1023/A:1025640625004. PMID: 26140906.
Copy Download .nbib Format: NLM
Genetic Library.

Journal of genetic counseling

Resta RG.
PMID: 26142110
J Genet Couns. 1999 Jun;8(3):183-6. doi: 10.1023/A:1022838807403.

No abstract available.

Cite
Resta RG. Genetic Library. J Genet Couns. 1999;8(3):183-6doi: 10.1023/A:1022838807403.
Resta, R. G. (1999). Genetic Library. Journal of genetic counseling, 8(3), 183-6. https://doi.org/10.1023/A:1022838807403
Resta, R G. "Genetic Library." Journal of genetic counseling vol. 8,3 (1999): 183-6. doi: https://doi.org/10.1023/A:1022838807403
Resta RG. Genetic Library. J Genet Couns. 1999 Jun;8(3):183-6. doi: 10.1023/A:1022838807403. PMID: 26142110.
Copy Download .nbib Format: NLM
Genetic Library.

Journal of genetic counseling

Resta RG.
PMID: 26141321
J Genet Couns. 2000 Jun;9(3):267-70. doi: 10.1023/A:1009420122804.

No abstract available.

Cite
Resta RG. Genetic Library. J Genet Couns. 2000;9(3):267-70doi: 10.1023/A:1009420122804.
Resta, R. G. (2000). Genetic Library. Journal of genetic counseling, 9(3), 267-70. https://doi.org/10.1023/A:1009420122804
Resta, R G. "Genetic Library." Journal of genetic counseling vol. 9,3 (2000): 267-70. doi: https://doi.org/10.1023/A:1009420122804
Resta RG. Genetic Library. J Genet Couns. 2000 Jun;9(3):267-70. doi: 10.1023/A:1009420122804. PMID: 26141321.
Copy Download .nbib Format: NLM
Cord Blood as a Source of Natural Killer Cells.

Frontiers in medicine

Mehta RS, Shpall EJ, Rezvani K.
PMID: 26779484
Front Med (Lausanne). 2016 Jan 05;2:93. doi: 10.3389/fmed.2015.00093. eCollection 2015.

Cord blood (CB) offers several unique advantages as a graft source for hematopoietic stem cell transplantation (HSCT). The risk of relapse and graft vs. host disease after cord blood transplantation (CBT) is lower than what is typically observed after...

Cite
Mehta RS, Shpall EJ, Rezvani K. Cord Blood as a Source of Natural Killer Cells. Front Med (Lausanne). 2016;2:93doi: 10.3389/fmed.2015.00093.
Mehta, R. S., Shpall, E. J., & Rezvani, K. (2015). Cord Blood as a Source of Natural Killer Cells. Frontiers in medicine, 293. https://doi.org/10.3389/fmed.2015.00093
Mehta, Rohtesh S, et al. "Cord Blood as a Source of Natural Killer Cells." Frontiers in medicine vol. 2 (2015): 93. doi: https://doi.org/10.3389/fmed.2015.00093
Mehta RS, Shpall EJ, Rezvani K. Cord Blood as a Source of Natural Killer Cells. Front Med (Lausanne). 2016 Jan 05;2:93. doi: 10.3389/fmed.2015.00093. eCollection 2015. PMID: 26779484; PMCID: PMC4700256.
Copy Download .nbib Format: NLM
Engineering cord blood to improve engraftment after cord blood transplant.

Stem cell investigation

Mehta RS, Dave H, Bollard CM, Shpall EJ.
PMID: 28607915
Stem Cell Investig. 2017 May 25;4:41. doi: 10.21037/sci.2017.05.01. eCollection 2017.

Umbilical cord blood transplant (CBT) has traditionally been associated with slower engraftment of neutrophils, delayed immune reconstitution and consequently higher risk of infections as compared with peripheral blood progenitor cell (PBPC) or bone marrow (BM) transplants. This is primarily...

Cite
Mehta RS, Dave H, Bollard CM, et al. Engineering cord blood to improve engraftment after cord blood transplant. Stem Cell Investig. 2017;4:41doi: 10.21037/sci.2017.05.01.
Mehta, R. S., Dave, H., Bollard, C. M., & Shpall, E. J. (2017). Engineering cord blood to improve engraftment after cord blood transplant. Stem cell investigation, 441. https://doi.org/10.21037/sci.2017.05.01
Mehta, Rohtesh S, et al. "Engineering cord blood to improve engraftment after cord blood transplant." Stem cell investigation vol. 4 (2017): 41. doi: https://doi.org/10.21037/sci.2017.05.01
Mehta RS, Dave H, Bollard CM, Shpall EJ. Engineering cord blood to improve engraftment after cord blood transplant. Stem Cell Investig. 2017 May 25;4:41. doi: 10.21037/sci.2017.05.01. eCollection 2017. PMID: 28607915; PMCID: PMC5460100.
Copy Download .nbib Format: NLM
Genetic library.

Journal of genetic counseling

Resta RG.
PMID: 24242231
J Genet Couns. 1993 Mar;2(1):63-5. doi: 10.1007/BF00962559.

No abstract available.

Cite
Resta RG. Genetic library. J Genet Couns. 1993;2(1):63-5doi: 10.1007/BF00962559.
Resta, R. G. (1993). Genetic library. Journal of genetic counseling, 2(1), 63-5. https://doi.org/10.1007/BF00962559
Resta, R G. "Genetic library." Journal of genetic counseling vol. 2,1 (1993): 63-5. doi: https://doi.org/10.1007/BF00962559
Resta RG. Genetic library. J Genet Couns. 1993 Mar;2(1):63-5. doi: 10.1007/BF00962559. PMID: 24242231.
Copy Download .nbib Format: NLM
Genetic library.

Journal of genetic counseling

Resta RG.
PMID: 24242319
J Genet Couns. 1993 Jun;2(2):115-7. doi: 10.1007/BF00962543.

No abstract available.

Cite
Resta RG. Genetic library. J Genet Couns. 1993;2(2):115-7doi: 10.1007/BF00962543.
Resta, R. G. (1993). Genetic library. Journal of genetic counseling, 2(2), 115-7. https://doi.org/10.1007/BF00962543
Resta, R G. "Genetic library." Journal of genetic counseling vol. 2,2 (1993): 115-7. doi: https://doi.org/10.1007/BF00962543
Resta RG. Genetic library. J Genet Couns. 1993 Jun;2(2):115-7. doi: 10.1007/BF00962543. PMID: 24242319.
Copy Download .nbib Format: NLM
The crane's foot: The rise of the pedigree in human genetics.

Journal of genetic counseling

Resta RG.
PMID: 24242747
J Genet Couns. 1993 Dec;2(4):235-60. doi: 10.1007/BF00961574.

The standard pedigree used by geneticists is intimately connected to the history of genetics. Pedigrees drawn today are based on standards established in the early decades of the twentieth century. Those standards were established by geneticists who pursued an...

Cite
Resta RG. The crane's foot: The rise of the pedigree in human genetics. J Genet Couns. 1993;2(4):235-60doi: 10.1007/BF00961574.
Resta, R. G. (1993). The crane's foot: The rise of the pedigree in human genetics. Journal of genetic counseling, 2(4), 235-60. https://doi.org/10.1007/BF00961574
Resta, R G. "The crane's foot: The rise of the pedigree in human genetics." Journal of genetic counseling vol. 2,4 (1993): 235-60. doi: https://doi.org/10.1007/BF00961574
Resta RG. The crane's foot: The rise of the pedigree in human genetics. J Genet Couns. 1993 Dec;2(4):235-60. doi: 10.1007/BF00961574. PMID: 24242747.
Copy Download .nbib Format: NLM
Editorial introduction.

Journal of genetic counseling

Resta RG.
PMID: 24234721
J Genet Couns. 1996 Dec;5(4):153-4. doi: 10.1007/BF01408369.

No abstract available.

Cite
Resta RG. Editorial introduction. J Genet Couns. 1996;5(4):153-4doi: 10.1007/BF01408369.
Resta, R. G. (1996). Editorial introduction. Journal of genetic counseling, 5(4), 153-4. https://doi.org/10.1007/BF01408369
Resta, R G. "Editorial introduction." Journal of genetic counseling vol. 5,4 (1996): 153-4. doi: https://doi.org/10.1007/BF01408369
Resta RG. Editorial introduction. J Genet Couns. 1996 Dec;5(4):153-4. doi: 10.1007/BF01408369. PMID: 24234721.
Copy Download .nbib Format: NLM
Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Translational oncology

Chen JH, Yu HJ, Hsu C, Mehta RS, Carpenter PM, Su MY.
PMID: 26055178
Transl Oncol. 2015 Jun;8(3):204-9. doi: 10.1016/j.tranon.2015.04.001.

PURPOSE: This study investigated the association between background parenchymal enhancement (BPE) and pathologic response to neoadjuvant chemotherapy (NAC).METHODS: A total of 46 patients diagnosed with invasive breast cancer were analyzed. Each patient had three magnetic resonance imaging (MRI) studies,...

Cite
Chen JH, Yu HJ, Hsu C, et al. Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Transl Oncol. 2015;8(3):204-9doi: 10.1016/j.tranon.2015.04.001.
Chen, J. H., Yu, H. J., Hsu, C., Mehta, R. S., Carpenter, P. M., & Su, M. Y. (2015). Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Translational oncology, 8(3), 204-9. https://doi.org/10.1016/j.tranon.2015.04.001
Chen, Jeon Hor, et al. "Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy." Translational oncology vol. 8,3 (2015): 204-9. doi: https://doi.org/10.1016/j.tranon.2015.04.001
Chen JH, Yu HJ, Hsu C, Mehta RS, Carpenter PM, Su MY. Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Transl Oncol. 2015 Jun;8(3):204-9. doi: 10.1016/j.tranon.2015.04.001. PMID: 26055178; PMCID: PMC4487259.
Copy Download .nbib Format: NLM
Minimal change disease: a variant of lupus nephritis.

NDT plus

Moysés-Neto M, Costa RS, Rodrigues FF, Vieira Neto OM, Reis MA, Louzada Júnior P, Romão EA, Dantas M.
PMID: 25984093
NDT Plus. 2011 Feb;4(1):20-2. doi: 10.1093/ndtplus/sfq179. Epub 2010 Oct 22.

Some patients with systemic lupus erythematosus (SLE) present with nephrotic syndrome due to minimal change disease (MCD). Histopathological diagnosis of patients with SLE and nephrotic-range proteinuria has shown that these patients present with diffuse proliferative glomerulonephritis and membranous glomerulonephritis,...

Cite
Moysés-Neto M, Costa RS, Rodrigues FF, et al. Minimal change disease: a variant of lupus nephritis. NDT Plus. 2010;4(1):20-2doi: 10.1093/ndtplus/sfq179.
Moysés-Neto, M., Costa, R. S., Rodrigues, F. F., Vieira Neto, O. M., Reis, M. A., Louzada Júnior, P., Romão, E. A., & Dantas, M. (2011). Minimal change disease: a variant of lupus nephritis. NDT plus, 4(1), 20-2. https://doi.org/10.1093/ndtplus/sfq179
Moysés-Neto, Miguel, et al. "Minimal change disease: a variant of lupus nephritis." NDT plus vol. 4,1 (2011): 20-2. doi: https://doi.org/10.1093/ndtplus/sfq179
Moysés-Neto M, Costa RS, Rodrigues FF, Vieira Neto OM, Reis MA, Louzada Júnior P, Romão EA, Dantas M. Minimal change disease: a variant of lupus nephritis. NDT Plus. 2011 Feb;4(1):20-2. doi: 10.1093/ndtplus/sfq179. Epub 2010 Oct 22. PMID: 25984093; PMCID: PMC4421630.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 280 entries